An Act Toxic-Free Medical Devices Act of 2025
By Ms. Lovely, a petition (accompanied by bill, Senate, No. 2579) (subject to Joint Rule 12) of Joan B. Lovely and James J. O'Day for legislation to ban the use of DEHP, a plasticizer found in IV bags and tubing, due to concerns about its potential health risks. Public Health.
Bill Information
Bill Information
- Presenter:
- Joan B. Lovely
- Status:
- Referred to Senate Committee on Ways and Means
The proposed bill aims to regulate the use of di(2-ethylhexyl) phthalate (DEHP) in medical products within Massachusetts. It sets a deadline of January 1, 2030, for the prohibition of the production, sale, or distribution of intravenous solution containers containing intentionally added DEHP. This restriction extends to intravenous tubing by January 1, 2035. Furthermore, the bill limits the replacement of DEHP with other ortho-phthalates in new or modified medical devices and caps the presence of unintentionally added DEHP in these products at 0.1% by weight. Exemptions to these rules include specific items such as human blood collection bags and cell therapy blood kits, based on federal regulations. Companies facing delays due to pending FDA approval or insufficient manufacturing capabilities must inform their customers in advance and may be granted an extension until January 1, 2032, if they demonstrate progress by specified dates.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.